His scientific interests lie mostly in Internal medicine, Surgery, Antibiotics, Antibacterial agent and Microbiology. His work carried out in the field of Internal medicine brings together such families of science as Vancomycin and Mycosis. His research is interdisciplinary, bridging the disciplines of Staphylococcus aureus and Surgery.
His work focuses on many connections between Antibiotics and other disciplines, such as Methicillin-resistant Staphylococcus aureus, that overlap with his field of interest in Staphylococcal infections and Minimum inhibitory concentration. In his work, Enterococcus faecalis, Aminoglycoside and Mortality rate is strongly intertwined with Enterococcus, which is a subfield of Antibacterial agent. He interconnects Pseudomonas aeruginosa, Proteus mirabilis and Veterinary medicine in the investigation of issues within Microbiology.
Marcus J. Zervos mainly investigates Microbiology, Internal medicine, Vancomycin, Methicillin-resistant Staphylococcus aureus and Staphylococcus aureus. His work in the fields of Microbiology, such as Enterococcus faecium, Antibacterial agent and Enterococcus, overlaps with other areas such as Pulsed-field gel electrophoresis. His Internal medicine research incorporates elements of Antibiotics, Surgery and Intensive care medicine.
Marcus J. Zervos focuses mostly in the field of Intensive care medicine, narrowing it down to topics relating to Epidemiology and, in certain cases, Infection control. The various areas that Marcus J. Zervos examines in his Methicillin-resistant Staphylococcus aureus study include Bacteremia and Staphylococcal infections. His study looks at the relationship between Staphylococcus aureus and fields such as Antimicrobial, as well as how they intersect with chemical problems.
Marcus J. Zervos mainly focuses on Internal medicine, Methicillin-resistant Staphylococcus aureus, Microbiology, Antimicrobial stewardship and Bacteremia. His study in the field of Respiratory failure, Retrospective cohort study, Prospective cohort study and Incidence is also linked to topics like Hydroxychloroquine. The Incidence study which covers Kidney disease that intersects with Intensive care unit and Odds ratio.
His research integrates issues of Enterococcus, Colonization and Vancomycin-resistant Enterococcus in his study of Methicillin-resistant Staphylococcus aureus. His studies in Microbiology integrate themes in fields like Daptomycin resistance and Staphylococcus aureus. Marcus J. Zervos has researched Bacteremia in several fields, including Pseudomonas aeruginosa and Vancomycin, Daptomycin.
His primary areas of study are Methicillin-resistant Staphylococcus aureus, Internal medicine, Bacteremia, Retrospective cohort study and Vancomycin. Marcus J. Zervos has included themes like Enterococcus, Colonization and Vancomycin-resistant Enterococcus in his Methicillin-resistant Staphylococcus aureus study. Marcus J. Zervos is interested in Prospective cohort study, which is a branch of Internal medicine.
Bacteremia is a subfield of Microbiology that Marcus J. Zervos studies. His Microbiology research is multidisciplinary, relying on both Biomarker, Skin and skin structure infection and Staphylococcus aureus. His Vancomycin research includes elements of Salvage therapy, Antibiotic resistance and Combination therapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Candiduria: A Randomized, Double-Blind Study of Treatment with Fluconazole and Placebo
J. D. Sobel;C. A. Kauffman;D. McKinsey;M. Zervos.
Clinical Infectious Diseases (2000)
Application of Molecular Techniques to the Study of Hospital Infection
Aparajita Singh;Richard V. Goering;Shabbir Simjee;Steven L. Foley.
Clinical Microbiology Reviews (2006)
Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study.
Emanuel N. Vergis;Mary K. Hayden;Joseph W. Chow;David R. Snydman.
Annals of Internal Medicine (2001)
Trends in US hospital admissions for skin and soft tissue infections.
John Edelsberg;Charu Taneja;Marcus Zervos;Nadia Haque.
Emerging Infectious Diseases (2009)
Thrombocytopenia Associated with Linezolid Therapy
Kinan Attassi;Ellie Hershberger;Rabiul Alam;Marcus J. Zervos;Marcus J. Zervos.
Clinical Infectious Diseases (2002)
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.
Samia Arshad;Paul Kilgore;Zohra S. Chaudhry;Gordon Jacobsen.
International Journal of Infectious Diseases (2020)
Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study.
Daniel H Kett;Ennie Cano;Andrew A Quartin;Julie E Mangino.
Lancet Infectious Diseases (2011)
Epidemiology and Outcomes of Community-Associated Methicillin-Resistant Staphylococcus aureus Infection
S. L. Davis;S. L. Davis;M. B. Perri;S. M. Donabedian;C. Manierski.
Journal of Clinical Microbiology (2007)
Bacteremia in Narcotic Addicts at the Detroit Medical Center. II. Infectious Endocarditis: A Prospective Comparative Study
Donald P. Levine;Lawrence R. Crane;Marcus J. Zervos.
Clinical Infectious Diseases (1986)
Pertussis: Microbiology, Disease, Treatment, and Prevention
Paul E. Kilgore;Abdulbaset M. Salim;Marcus J. Zervos;Heinz Josef Schmitt;Heinz Josef Schmitt.
Clinical Microbiology Reviews (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: